臨床婦人科産科73巻2号

2019年03月発行

今月の臨床 NIPT新時代の幕開け―検査の実際と将来展望

NIPTの現状

NIPT検査実施に際しての遺伝カウンセリングの留意点は？

著者： 西山深雪¹

所属機関： ¹国立成育医療研究センター周産期・母性診療センター

ページ範囲：P.228 - P.236

文献概要

●NIPTは出生前遺伝学的検査の1つの選択肢に過ぎない．クライアントが各検査を理解して納得した選択ができるよう，正確な情報提供と意思決定の支援が求められる．

●NIPTの最大の特徴は，従来の非確定的検査よりも陽性的中率が高くなることである．

●出生前遺伝学的検査は，望まない結果であった際のことをクライアントが事前に考えておく必要のある検査である．

参考文献

1）American College of Obstetricians and Gynecologists' Committee on Practice Bulletin No. 162 : prenatal diagnostic testing for genetic disorders. Obstet Gynecol 127 : 108-122, 2016

2）American College of Obstetricians and Gynecologists' Committee on Practice Bulletin No. 163 : Screening for fetal aneuploidy. Obstet Gynecol 127 : 123-137, 2016

3）Gagnon A, et al : Obstetrical complications associated with abnormal maternal serum markers analytes. J Obstet Gynaecol Can 30 : 918-949, 2008

4）Malan V, et al : Effect of cell-free DNA screening vs direct invasive diagnosis on miscarriage rates in women with pregnancies at high risk of trisomy 21 : a randomized clinical trial. JAMA 320 : 557-565, 2018

5）Bianchi DW, et al : DNA sequencing versus standard prenatal aneuploidy screening. N Engl J Med 370 : 799-808, 2014

6）Norton ME, et al : Cell-free DNA analysis for noninvasive examination of trisomy. N Engl J Med 372 : 1589-1597, 2015

7）Gil MM, et al : Clinical implementation of routine screening for fetal trisomies in the UK NHS : cell-free DNA test contingent on results from first-trimester combined test. Ultrasound Obstet Gynecol 47 : 45-52, 2016

8）See comment in PubMed Commons belowOepkes D, et al : Trial by Dutch laboratories for evaluation of non-invasive prenatal testing part I-clinical impact. Prenat Diagn 36 : 1083-1090, 2016

9）Yotsumoto J, et al : A survey on awareness of genetic counseling for non-invasive prenatal testing : the first year experience in Japan. J Hum Genet 61 : 995-1001, 2016

10）西山深雪，他 : Non-invasive prenatal genetic testingの遺伝カウンセリング担当者に対する質問紙調査．日遺伝カウンセリング会誌37 : 11-20, 2016

11）Nishiyama M, et al : Factors affecting parental decisions to terminate pregnancy in the presence of chromosome abnormalities : a Japanese multicenter study. Prenat Diagn 36 : 1121-1126, 2016

12）tyuuNiNiNLi DK, et al : Factors influencing women's acceptance of prenatal screening tests. Prenat Diagn 28 : 1136-1143, 2008

13）Julian-Reynier C, et al : Reasons for women's non-uptake of amniocentesis. Prenat Diagn 14 : 859-864, 1994

14）日本産科婦人科学会倫理委員会 : 母体血を用いた新しい出生前遺伝学的検査に関する指針, 2013　http://www.jsog.or.jp/news/pdf/guidelineForNIPT_20130309.pdf

15）Samura O, et al : Current status of non-invasive prenatal testing in Japan. J Obstet Gynaecol Res 43 : 1245-1255, 2017

16）Bianchi DW, et al : Sequencing of circulating cell-free DNA during pregnancy. N Engl J Med 379 : 464-473, 2018

17）Hartwig TS, et al : Discordant non-invasive prenatal testing（NIPT） -a systematic review. Prenat Diagn 37 : 527-539, 2017

18）Benn P, et al : Position statement from the chromosome abnormality screening committee on behalf of the board of the International Society for Prenatal Diagnosis. Prenat Diagn 35 : 725-34.2015

19）Burns W, et al : The association between anticoagulation therapy, maternal characteristics, and a failed cfDNA test due to a low fetal fraction. Prenat Diagn 37 : 1125-1129, 2017

20）Bianchi DW, et al : Cherchez la femme : maternal incidental findings can explain discordant prenatal cell-free DNA sequencing results. Genet Med 20 : 910-917, 2018